You searched for "foundation"
Conjunctival inflammation in glaucoma patients
1 April 2015
| Khadijah Basheer
|
EYE - Glaucoma
Numerous studies have demonstrated that topical medications and preservatives used for the management of glaucoma can induce significant histopathologic and inflammatory changes in the ocular surface. This study describes an increased expression of major histocompatibility complex class II antigen HLA-DR,...
Glaucoma surgery in Sturge-Weber syndrome
The authors report the largest retrospective study of surgical results of goniotomoy and trabeculectomy for 42 patients (46 eyes) with glaucoma associated with Sturge-Weber syndrome (SWS). There were 18 males and 24 females, and 62 goniotomy procedures (51 goniotomy surgery,...
Possible mechanism for infant development of secondary glaucoma
The authors consider published evidence with regard to potential causative mechanisms for secondary glaucoma that follows infant lensectomy. They review clinical and laboratory studies. The mechanism they propose is that the original lensectomy surgery releases immature anterior lens cells into...Take part in the 'Whole Eye OCT Experience' at 100% Optical 2024
5 February 2024
|
oct, Whole Eye, 100%, optical, ophthalmology, event, conference, London, Heidelberg
The Whole Eye OCT Experience is being delivered in association with The Partially Sighted Society: a charity that helps anybody living with vision loss make the best use of their remaining vision.
Glaucoma UK’s World Glaucoma Week campaign to increase awareness of glaucoma risk factors
16 March 2023
World Glaucoma Week is an annual initiative which brings health organisation and charities from around the world together to amplify health messages relating to glaucoma and raise awareness of the disease.
Nano-ophthalmology paves a new path in the future of eyecare
1 December 2022
| Stylianos Mastronikolis, Jayasis Bandyopadhyay
|
EYE - General
Introduction The treatments of ocular conditions in the field of ophthalmology varies from topical to surgical procedures. The field of nanotechnology is one of the fast-growing fields of medicine, which plays an important role in turning the impossibilities of the...
Optic nerve swelling – your survival guide (part 1)
1 August 2017
| Ali Yagan
|
EYE - Neuro-ophthalmology
Assessment of optic nerve appearance and functions is a daily routine in neuro-ophthalmology. Following a recent high profile court case there has been a significant increase in the amount of referral to ophthalmology departments to assess the optic nerve and...
World Clinics in Ophthalmology Series: Innovations in Primary Open Angle Glaucoma
1 April 2014
| Subhanjan Mukherji
|
EYE - Glaucoma, EYE - General, EYE - Paediatrics, EYE - Strabismus, EYE - Neuro-ophthalmology
This two volume publication about current innovations in primary open angle glaucoma has persevered to come out with a comprehensive review of the latest publications in the world of glaucoma. The list of contributors includes clinicians from the field of...
The world in union
4 October 2023
| David Lockington, Baljean Dhillon (Prof)
"It’s the world in union, the world as one…” Hearing these lyrics as a sports fan means only one thing: it’s time for the Rugby World Cup! This four-yearly sporting extravaganza should hit your TV screens around the same time...
Cytokine levels in vitreous fluid in patients with pathological myopia
1 April 2020
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Pathological myopia (PM) is a leading cause of irreversible visual impairment worldwide, and efforts are dedicated to the study of its underlying mechanisms. Axial extension of the eyeball is regulated via a cascade of biochemical molecules that are initiated in...
How does low-concentration atropine reduce progression of myopia?
This is a double-blind, randomised, placebo-controlled trial evaluating the effects of low-concentration atropine (0.05%, 0.025%, 0.01%) on ocular biometrics of myopic children. The aim is to determine what aspect of ocular biometrics low-concentration atropine influenced in reducing the progression of...Exploiting nature’s randomised trials of eye disease
1 December 2022
| Skanda Rajasundaram, Dalia Abdulhussein, Christopher Bentley (Prof), Shafi Balal, Minak Bhalla
|
EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Orbit
Confounding and reverse causation in observational ophthalmic epidemiology Traditional observational studies are inherently limited in establishing a causal effect of an exposure on an outcome of interest. One fundamental limitation is confounding, whereby causation is incorrectly attributed to a third...
